newsfilter
← Latest News
GlobeNewswire·

RAPT Therapeutics Reports First Quarter 2024 Financial Results

SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral